APA

Weber J., Glutsch V., Geissinger E., Haug L., Lock J. F., Schneider F., Kneitz H., Goebeler M., Schilling B. & Gesierich A. (20210514). Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. : The British journal of dermatology.

Chicago

Weber J, Glutsch V, Geissinger E, Haug L, Lock J F, Schneider F, Kneitz H, Goebeler M, Schilling B and Gesierich A. 20210514. Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. : The British journal of dermatology.

Harvard

Weber J., Glutsch V., Geissinger E., Haug L., Lock J. F., Schneider F., Kneitz H., Goebeler M., Schilling B. and Gesierich A. (20210514). Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. : The British journal of dermatology.

MLA

Weber J, Glutsch V, Geissinger E, Haug L, Lock J F, Schneider F, Kneitz H, Goebeler M, Schilling B and Gesierich A. Neoadjuvant immunotherapy with combined ipilimumab and nivolumab in patients with melanoma with primary or in transit disease. : The British journal of dermatology. 20210514.